• Nanoform's Clinical Study Indicates Positive Interim Results prnasia
    January 22, 2021
    Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, today announced positive interim results from its clinical study. The faster absorption data implies that small particles can indeed be powerful.
PharmaSources Customer Service